Sema4 Holdings Corp. reaffirmed its earnings guidance for the full year and second half 2022. Sema4 is maintaining the previously issued full year and second half 2022 reported revenue guidance of $245 million to $255 million and $154 million to $164 million, respectively.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.72 USD | -1.35% | -17.90% | +617.09% |
04-30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
04-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+617.09% | 516M | |
-23.07% | 8.1B | |
+2.03% | 2.57B | |
-7.71% | 2.49B | |
-40.47% | 2.39B | |
-14.15% | 1.77B | |
-20.84% | 1.53B | |
-42.17% | 1.18B | |
+16.01% | 1.2B | |
+14.81% | 956M |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- Sema4 Holdings Corp. Reaffirms Its Earnings Guidance for the Full Year and Second Half 2022